Citigroup Inc.
NYSE:CBanks - Diversified
+$0.24 today
- Market cap
- $194.16B
- Beta
- 1.11
- P/E (TTM)
- 15.6
- EPS (TTM)
- $9.21
- Dividend yield
- 1.67%
Volume 10.45M
Average 12.37M
C Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Citigroup Inc.NYSE: C
Capital Expenditures · Q2 FY2026 · quarter ended Jun 2026
Capital expenditures declines year over year
Q2 FY2026 capital expenditures of $1.55B (cash outflow) fell 11.6% year over year, behind the -4.7% change in trailing-twelve-month capital expenditures. Sequentially, it rose 9.6% from the prior quarter. Over 3 fiscal years it compounded at +5.0% a year.
Context
- Capital expenditures amounted to 3.9% of revenue in FY2025, unchanged from a year earlier.
- Capital expenditures grew in size in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -11.6% toward the trailing-twelve-month pace of -4.7%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (6.52B) USD
- Year-over-year change
- -0.3%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (6.52B) | -0.3% |
| FY2024 | 2024-12-31 | (6.5B) | +1.3% |
| FY2023 | 2023-12-31 | (6.58B) | -16.9% |
| FY2022 | 2022-12-31 | (5.63B) | -36.7% |
| FY2021 | 2021-12-31 | (4.12B) | — |
Capital Expenditures vs competitors
How C compares with its peers on the latest reported figures
- Peers report in different currencies, so capital expenditures is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -4.7% is the 3rd highest of 5, against a peer median of -8.1%.
- Capital expenditures amounts to 3.6% of revenue for C, versus a peer median of 0.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | ¥326.48B JPY | — | +18.8% | 2.4% | |
| LTM Jun 2026 | $6.21B USD | -4.7% | +5.0% | 3.6% | |
| LTM Mar 2026 | €3.33B EUR | -57.6% | -10.9% | 4.7% | |
| LTM Jun 2026 | $2.16B USD | +6.4% | -18.0% | 1.8% | |
| LTM Mar 2026 | $1.67B USD | -22.6% | +4.5% | 2.2% | |
| LTM Sep 2026 | $616M USD | +120.1% | -2.0% | 0.5% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Jun 2026 | $0 USD | — | +1.9% | 0.0% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Jun 2026 | €0 EUR | — | — | 0.0% | |
| Peer median (excluding C) | — | -8.1% | -0.1% | 0.2% | |
Competitors are the stored peer set for C. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 21.95B | 15.08B | 9.23B | 12.68B | 14.31B |
| Depreciation & Amortization | 3.96B | 4.26B | 4.56B | 4.31B | 4.37B |
| Deferred Income Tax | 1.41B | (1.14B) | (2.42B) | (1.9B) | 452M |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 |
| Change in Working Capital | 38.86B | 19.55B | (99.39B) | (59.03B) | (84.87B) |
| Accounts Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital | 38.86B | 19.55B | (99.39B) | (59.03B) | (84.87B) |
| Other Non-Cash Items | (19.1B) | (12.68B) | 14.6B | 24.26B | (1.89B) |
| Operating Cash Flow | 47.09B | 25.07B | (73.42B) | (19.67B) | (67.63B) |
| Capital Expenditures | (4.12B) | (5.63B) | (6.58B) | (6.5B) | (6.52B) |
| Acquisitions (Net) | 190M | 5.74B | (1.39B) | 0 | 0 |
| Purchases of Investments | (391.73B) | (261.65B) | (236.51B) | (267.42B) | (281.52B) |
| Sales of Investments | 271.08B | 232.81B | 255.16B | 301.64B | 330.24B |
| Other Investing Activities | 13.84B | (50.72B) | (19.13B) | 58.53B | (150.48B) |
| Investing Cash Flow | (110.75B) | (79.46B) | (8.46B) | 86.25B | (108.28B) |
| Debt Repayment | (5.83B) | 66.79B | (8.78B) | 17.17B | 22.08B |
| Common Stock Issued | 3.3B | 0 | 2.74B | 5.28B | 7.19B |
| Common Stock Repurchased | (11.39B) | (3.25B) | (6.12B) | (7.52B) | (18.25B) |
| Dividends Paid | (5.2B) | (5B) | (5.21B) | (5.2B) | (5.37B) |
| Other Financing Activities | 36.39B | 79.23B | 18.06B | (48.03B) | 232.39B |
| Financing Cash Flow | 17.27B | 137.76B | 687M | (38.3B) | 238.03B |
| Effect of Forex Changes | (1.2B) | (3.39B) | 95M | (12.68B) | 10.93B |
| Net Change in Cash | (47.58B) | 79.99B | (81.09B) | 15.6B | 73.05B |
| Free Cash Flow | 42.97B | 19.44B | (80B) | (26.17B) | (74.15B) |
Citigroup Inc.
NYSE:C
Intrinsic Alpha fair value
Locked
Current Price
$117.30
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.